Researchers 'cautiously optimistic' about desert bighorn sheep recovery in Mojave Desert

February 21, 2021

CORVALLIS, Ore. - Desert bighorn sheep in the Mojave National Preserve in California and surrounding areas appear to be more resilient than previously thought to a respiratory disease that killed dozens of them and sickened many more in 2013, a new study has found.

Clint Epps, a wildlife biologist at Oregon State University, and several co-authors, found that exposure to one of the bacteria associated with the disease is more widespread among bighorn sheep populations in the Mojave, and that its presence dates further back, than scientists thought. But they also found that the overall number of infected bighorn has declined since 2013 in the populations surveyed.

Epps and his colleagues, including Nicholas Shirkey, an environmental scientist with the California Department of Fish and Wildlife and lead author of the paper in the Journal of Wildlife Diseases, are cautiously optimistic about what they found.

"I wouldn't let my guard down, but I have been heartened to see that the bighorn are hanging on," said Epps, a professor in OSU's College of Agricultural Sciences.

The 2013 respiratory disease outbreak puzzled scientists, who grew concerned that the disease could impact the long-term future of one of the few large mammals that can live in this harsh desert environment. Desert bighorn sheep, which weigh up to 250 pounds, are notable for their large curled horns and ability to climb steep, rocky terrain with speed and agility. They live in California, Nevada, Utah, Arizona, New Mexico and Texas, as well as Mexico.

Epps, who began studying desert bighorn sheep in 1999, said they are a species that brings people together.

"I've seen people from all walks of life - people who are hunters, people who are desert aficionados, people who love biodiversity, people who just love these things for their iconic beauty - all coming together around the conservation management of this species," he said. "I have seen some really unusual partnerships."

Shirkey added that the rare animals captivate people. "There's fewer than 5,000 desert bighorn in the state of California," he said. "There's probably that many deer in parts of some counties. They live in small numbers in very difficult places and even just seeing one, you feel like you've gotten to have a real special experience."

The paper, published in the Journal of Wildlife Diseases, describes the results from testing blood samples of captured bighorn sheep for antibodies to Mycoplasma ovipneumoniae, a pathogen associated with respiratory disease in the animal.

The 2013 outbreak of the pathogen mobilized interest in the Mojave populations of desert bighorn sheep, leading the California Department of Fish and Wildlife, the National Park Service, Epps and other partners to capture and release more animals to obtain blood samples to check their health and monitor population trends.

The Mojave Desert occupies about 43,000 square miles, of which 59% is in California. The California piece of the Mojave is about the size of the state of West Virginia. That large size leads to distinct, though connected, populations of desert bighorn sheep throughout the Mojave in California. The California Department of Fish and Wildlife has captured sheep in 16 different mountain ranges.

In 2013, they captured 70 desert bighorn sheep in eight of those populations. Sixty percent of them had antibodies to Mycoplasma ovipneumoniae, the pathogen that causes the respiratory diseases. In four subsequent years of capturing bighorn sheep in up to 12 of those regions, between 12% and 15% had the antibodies. While the percentage of bighorn with antibodies has declined across most populations since 2013, the researchers continue to identify additional ranges where the pathogen has been present.

The researchers also tested blood samples that had been collected from desert bighorn sheep during the 1980s, 1990s and 2000s. The samples they tested, which are archived by the California Department of Fish and Wildlife, only represented four of the 16 populations.

The researchers found evidence that bighorn sheep in those populations had been exposed to that pathogen in all three of those decades, leading them to question whether the antibodies were to the same strain as that observed during the 2013 outbreak or a less virulent strain. In one case, a population with evidence of exposure in 1989-90 appeared to have cleared the pathogen several years later, with subsequent tests failing to detect exposure until the 2013 outbreak.

"The findings in the paper show the importance of a sustained effort to collect data from these desert bighorn sheep," Epps said. "The data really help us understand what is happening with these populations so that we can make sure they survive."
In addition to Epps and Shirkey, authors of the paper are: Annette Roug (shared first author), Thomas Besser, Vernon C. Bleich, Neal Darby, Daniella Dekelaita, Nathan Galloway, Ben Gonzales, Debra Hughson, Lora Konde, Ryan Monello, Paige R. Prentice, Regina Vu, John Wehausen, Brandon Munk (shared senior author) and Jenny Powers (shared senior author.)

Funding for the research was provided by California Department of Fish and Game Federal Aid in Wildlife Restoration Project, Boone and Crockett Club, California Association of Professional Scientists, Foundation for North American Wild Sheep, National Rifle Association, Safari Club International, San Bernardino County Fish and Game Commission, Society for the Conservation of Bighorn Sheep, U.S. Department of Interior Bureau of Land Management, California Department of Fish and Wildlife, National Park Service, Oregon State University, Nevada Department of Wildlife, California Chapter of the Wild Sheep Foundation and the Desert Bighorn Council.

Oregon State University

Related Antibodies Articles from Brightsurf:

Scientist develops new way to test for COVID-19 antibodies
New research details how a cell-free test rapidly detects COVID-19 neutralizing antibodies and could aid in vaccine testing and drug discovery efforts.

Mussels connect antibodies to treat cancer
POSTECH research team develops innovative local anticancer immunotherapy technology using mussel protein.

For an effective COVID vaccine, look beyond antibodies to T-cells
Most vaccine developers are aiming solely for a robust antibody response against the SARS-CoV-2 virus, despite evidence that antibodies are not the body's primary protective response to infection by coronaviruses, says Marc Hellerstein of UC Berkeley.

Children can have COVID-19 antibodies and virus in their system simultaneously
With many questions remaining around how children spread COVID-19, Children's National Hospital researchers set out to improve the understanding of how long it takes pediatric patients with the virus to clear it from their systems, and at what point they start to make antibodies that work against the coronavirus.

The behavior of therapeutic antibodies in immunotherapy
Since the late 1990s, immunotherapy has been the frontline treatment against lymphomas where synthetic antibodies are used to stop the proliferation of cancerous white blood cells.

Re-engineering antibodies for COVID-19
Catholic University of America researcher uses 'in silico' analysis to fast-track passive immunity

Seroprevalence of antibodies to SARS-CoV-2 in 10 US sites
This study estimates how common SARS-CoV-2 antibodies are in convenience samples from 10 geographic sites in the United States.

Neutralizing antibodies in the battle against COVID-19
An important line of defense against SARS-CoV-2 is the formation of neutralizing antibodies.

Three new studies identify neutralizing antibodies against SARS-CoV-2
A trio of papers describes several newly discovered human antibodies that target the SARS-CoV-2 virus, isolated from survivors of SARS-CoV-2 and SARS-CoV infection.

More effective human antibodies possible with chicken cells
Antibodies for potential use as medicines can be made rapidly in chicken cells grown in laboratories.

Read More: Antibodies News and Antibodies Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to